Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Rottneros
Mandate

Vinge has advised Rottneros

September 06, 2017

Vinge has advised Rottneros AB (publ) (“Rottneros”) in connection with an issue of unsecured bonds up to a total amount of SEK 600 million.

The bonds have a term of five years and floating interest of STIBOR 3M + 4.15 per cent. Swedbank has acted as financial adviser and sole bookrunner in connection with the bond issue.

The proceeds from the initial bond issue will be used as part of completing the financing of the strategic plan Agenda 500 and for achieving long-term efficiency of the Group's capital structure. The bonds are, in accordance with their terms and conditions, intended to be admitted to trading on the corporate bond list of Nasdaq Stockholm.

Vinge’s team consisted of Louise Salomon together with André Isacson and Lionardo Ojeda.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025